UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Asymmetric high-coordination Co-NSP single-atom catalysts with tailored d-p-orbital electron structure for efficient bifunctional catalyst of rechargeable Zn-air battery cathodes Journal article
Lv, Ze, Shu, Zheng, Luo, Jiawei, Xu, Jiawen, Ma, Yimeng, Zhang, Linping, Xu, Hong, Mao, Zhiping. Asymmetric high-coordination Co-NSP single-atom catalysts with tailored d-p-orbital electron structure for efficient bifunctional catalyst of rechargeable Zn-air battery cathodes[J]. Applied Catalysis B: Environmental, 2025, 365, 124889.
Authors:  Lv, Ze;  Shu, Zheng;  Luo, Jiawei;  Xu, Jiawen;  Ma, Yimeng; et al.
Favorite | TC[Scopus]:0  IF:20.2/18.9 | Submit date:2025/01/22
Single Atom Catalyst  Asymmetric Atomic Co Site  High Coordination  D-band Center  Zn-air Battery  
NXPH4 mediated by m5C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation Journal article
Lei Yang, Jiawen Shi, Mingyang Zhong, Pingping Sun, Xiaojing Zhang, Zhengyi Lian, Hang Yin, Lijun Xu, Guyin He, Haiyan Xu, Han Wu, Ziheng Wang, Kai Miao, Jianfei Huang. NXPH4 mediated by m5C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation[J]. CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29(1), 111.
Authors:  Lei Yang;  Jiawen Shi;  Mingyang Zhong;  Pingping Sun;  Xiaojing Zhang; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:1  IF:9.2/8.1 | Submit date:2024/08/28
Nxph4  M5 c Modifcation  Colorectal Cancer (Crc)  Rnautophagy  Hif Signaling Pathway  
Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy Journal article
Chen, Qian, Xu, Ligeng, Chen, Jiawen, Yang, Zhijuan, Liang, Chao, Yang, Yu, Liu, Zhuang. Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy[J]. BIOMATERIALS, 2017, 148, 69-80.
Authors:  Chen, Qian;  Xu, Ligeng;  Chen, Jiawen;  Yang, Zhijuan;  Liang, Chao; et al.
Favorite | TC[WOS]:88 TC[Scopus]:92  IF:12.8/13.1 | Submit date:2018/10/30
Erlotinib  Vascular Normalization  Tumor Microenvironment  Nanomedicine  Immunotherapy